Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cell-mediated immune function in NPC patients treated with cimetidine]

P Zeng1, J Xiao, Y Lei

  • 1Third Affiliated Hospital, Hunan Medical University, Changsha.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|May 1, 1995
PubMed
Summary

Cimetidine combined with radiation therapy may enhance immune response in nasopharyngeal cancer (NPC) patients. This combination therapy boosts CD4/CD8 ratio and IL-2 production, suggesting improved cell-mediated immunity during cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New insights on the association of weight loss with the reduction in carotid intima-media thickness among patients with obesity: an updated systematic review and meta-analysis.

Public health·2023
Same author

Aperiodic neural activity is a biomarker for depression severity.

medRxiv : the preprint server for health sciences·2023
Same author

Measurement of the top quark mass using a profile likelihood approach with the lepton + jets final states in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Observation of τ Lepton Pair Production in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2023
Same author

A search for decays of the Higgs boson to invisible particles in events with a top-antitop quark pair or a vector boson in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

[Research progress of biomaterials with ordered micro-nano structure in wound repair].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2023

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Nasopharyngeal cancer (NPC) patients undergoing radiotherapy often experience altered immune responses.
  • Radiotherapy alone can modulate T-cell populations and natural killer (NK) cell activity.
  • H2 receptor antagonists, like Cimetidine (CMD), are being investigated for their potential immunomodulatory effects in cancer treatment.

Purpose of the Study:

  • To evaluate the impact of Cimetidine (CMD) in combination with radiotherapy on cell-mediated immunity in NPC patients.
  • To assess changes in T-cell subsets (CD4+, CD8+), the CD4/CD8 ratio, and Interleukin-2 (IL-2) production.
  • To compare NK cell activity in patients receiving radiotherapy alone versus combined therapy with CMD.

Main Methods:

  • Patients with NPC were treated with either radiotherapy alone or a combination of radiotherapy and Cimetidine (CMD).

Related Experiment Videos

  • Immune parameters including CD4+ T cells, CD8+ T cells, CD4/CD8 ratio, IL-2 levels, and NK cell activity were measured.
  • Comparative analysis was performed between the two treatment groups.

    • Main Results:

    • Radiotherapy alone led to an increase in CD4+ T cells and NK cell activity.
    • Combined treatment with radiation and CMD resulted in a decrease in CD8+ T cells, an increased CD4/CD8 ratio, and elevated IL-2 production.
    • NK cell activity was significantly stronger in patients who received the combined radiation and CMD treatment.

    Conclusions:

    • Cimetidine (CMD) may play a role in restoring cell-mediated immunity in NPC patients undergoing radiation therapy.
    • The combination of CMD and radiation demonstrates a potentially beneficial immunomodulatory effect beyond radiotherapy alone.
    • Further research into CMD as an adjunct therapy for NPC could improve treatment outcomes by enhancing immune function.